CN119585444A - 人圆环病毒的鉴定 - Google Patents

人圆环病毒的鉴定 Download PDF

Info

Publication number
CN119585444A
CN119585444A CN202380053119.2A CN202380053119A CN119585444A CN 119585444 A CN119585444 A CN 119585444A CN 202380053119 A CN202380053119 A CN 202380053119A CN 119585444 A CN119585444 A CN 119585444A
Authority
CN
China
Prior art keywords
seq
hcirv
protein
peptide
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380053119.2A
Other languages
English (en)
Chinese (zh)
Inventor
P·佩罗
M·埃卢瓦
B·勒尼奥
N·达罗沙
A·雅梅
J·富尔若
M·勒吕埃-维勒
A·费罗尼
O·洛托拉里
C·鲁佐
D·克雷蒂安
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfre National Veterinary School
Western Dais Paris, University of
Assistance Publique Hopitaux de Paris APHP
Institut Pasteur
Original Assignee
Alfre National Veterinary School
Western Dais Paris, University of
Assistance Publique Hopitaux de Paris APHP
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfre National Veterinary School, Western Dais Paris, University of, Assistance Publique Hopitaux de Paris APHP, Institut Pasteur filed Critical Alfre National Veterinary School
Publication of CN119585444A publication Critical patent/CN119585444A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CN202380053119.2A 2022-05-18 2023-05-17 人圆环病毒的鉴定 Pending CN119585444A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263343205P 2022-05-18 2022-05-18
US63/343,205 2022-05-18
US202263373343P 2022-08-24 2022-08-24
US63/373,343 2022-08-24
PCT/IB2023/000264 WO2023223092A1 (en) 2022-05-18 2023-05-17 Identification of a human circovirus

Publications (1)

Publication Number Publication Date
CN119585444A true CN119585444A (zh) 2025-03-07

Family

ID=86904168

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380053119.2A Pending CN119585444A (zh) 2022-05-18 2023-05-17 人圆环病毒的鉴定

Country Status (5)

Country Link
EP (1) EP4526478A1 (https=)
JP (1) JP2025516796A (https=)
KR (1) KR20250075537A (https=)
CN (1) CN119585444A (https=)
WO (1) WO2023223092A1 (https=)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32011A (en) 1861-04-09 Coffee-pot
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4411993A (en) 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
US4543439A (en) 1982-12-13 1985-09-24 Massachusetts Institute Of Technology Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4902614A (en) 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5333675C1 (en) 1986-02-25 2001-05-01 Perkin Elmer Corp Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
DE3689123T2 (de) 1985-11-01 1994-03-03 Xoma Corp Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
CN110527717B (zh) * 2018-01-31 2023-08-18 完美（广东）日用品有限公司 用于2型糖尿病的生物标志物及其用途
US10982187B2 (en) * 2019-03-26 2021-04-20 Genus Plc Bos taurus variety ‘HO840003150607238’ and methods of use thereof
CN109943664A (zh) * 2019-03-27 2019-06-28 天津大学 一种猪圆环病毒3快速检测方法及其试剂盒

Also Published As

Publication number Publication date
WO2023223092A1 (en) 2023-11-23
JP2025516796A (ja) 2025-05-30
KR20250075537A (ko) 2025-05-28
EP4526478A1 (en) 2025-03-26

Similar Documents

Publication Publication Date Title
Wong et al. Advances in the diagnosis of foot-and-mouth disease
Barker et al. Limitations of using feline coronavirus spike protein gene mutations to diagnose feline infectious peritonitis
Pankuweit et al. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens
Diallo et al. Recent developments in the diagnosis of rinderpest and peste des petits ruminants
Pérot et al. Circovirus hepatitis infection in heart-lung transplant patient, France
CN112979788B (zh) 特异性结合HBeAg的结合蛋白、诊断HBV感染的试剂和试剂盒
US11299768B2 (en) Methods for determining a patient's susceptibility of contracting a nosocomial infection and for establishing a prognosis of the progression of septic syndrome
CN119585444A (zh) 人圆环病毒的鉴定
Latha et al. Development of recombinant nucleocapsid protein based IgM-ELISA for the early detection of distemper infection in dogs
Goossens et al. Early detection of cytomegalovirus in renal transplant recipients: comparison of PCR, NASBA, pp65 antigenemia, and viral culture
CN113004411B (zh) 可特异性结合ckmb的结合蛋白、其应用以及检测ckmb的方法
EP2413960B1 (en) Diagnostic test for avian nephritis virus
Xu et al. A Combined Method Based on the FIPV N Monoclonal Antibody Immunofluorescence Assay and RT‐nPCR Method for the Rapid Diagnosis of FIP‐Suspected Ascites
WO2008077511A1 (en) Human polyomavirus and methods of diagnosis and treatment
CN114163521A (zh) 一种鉴别猪瘟病毒2.1亚型强毒株及其抗体的单克隆抗体
US20070264651A1 (en) Methods, compositions, and kits for the detection and monitoring of kidney cancer
CN117625838A (zh) 一种猫细小病毒的胶体金raa法核酸检测试剂盒及其检测方法
JP2007145775A (ja) ノロウイルスｇｉの高感度検出方法
JPH11511027A (ja) Ｇｂ型肝炎ウィルス遺伝子型の検出
US20220235399A1 (en) Use of p44 as marker for diagnosing anaplasmosis
RU2823531C1 (ru) Способ диагностики вирусного репродуктивно-респираторного синдрома свиней с помощью флуоресцентной гибридизации in-situ (fish)
KR102900608B1 (ko) 바토넬라균 검출용 프라이머 세트
Wasissa et al. Feline coronavirus detection in clinically suspected feline infectious peritonitis cats
KR102900600B1 (ko) 리케치아균 검출용 프라이머 세트
US12529114B2 (en) Orthobunyavirus in human encephalitis and its diagnostic and therapeutic applications

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination